UF Scientist’s Parkinson’s Work Selected for Innovative Drug Development Effort

People with Parkinson’s need better treatment options, and they need them fast. A California nonprofit, SPARK NS, announced Tuesday that it has selected University of Florida chemist Matthew Disney, Ph.D., for an ambitious two-year effort to move promising Parkinson’s disease discoveries to patients.

Disney, chemistry department chair and Institute Professor at The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology, has pioneered ways to create RNA-targeted medicines. He is one of five scientists nationally whose projects were selected. The nonprofit will supply each scientist with up to $2 million and the expertise of more than 50 scientific and business advisers experienced in bringing new medicines to patients.

Read more about UF Scientist’s Parkinson’s Work Selected for Innovative Drug Development Effort.